These data support the putative mechanistic links between WNT4 and metabolic signaling identified in patient tumor RPPA, and reinforce that WNT4 signaling is a shared mechanism between ILC and gynecologic tumors. Here, WNT4 is linked to female reproductive system neoplasm.